BioNTech SE - ADR

XNAS:BNTX 4:00:00 PM EDT

98.86

+2.13 (+2.20%)

: $98.77 -0.09 (-0.09%)

Market Cap (Intraday)	25.38B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.23 Billion
Adjusted EPS	$0.86

See more estimates

10-Day MA	$99.94
50-Day MA	$96.98
200-Day MA	$97.64

See more pivots

BioNTech SE - ADR Stock, XNAS:BNTX

An der Goldgrube 12, Mainz, Rheinland-Pfalz 55131

Germany

Phone: +49.6131.9084.0

Number of Employees: 6772

http://www.biontech.de

Description

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.